HomeAIAI Funding & DealsShield to Buy Echodyne for $5.3bn and Raise $2.5bn

Shield to Buy Echodyne for $5.3bn and Raise $2.5bn

Shield has signed a definitive agreement to acquire Echodyne Corp., a Kirkland, Washington radar company whose sensors are built into counter-drone and security systems, in a transaction valued at $5.3 billion, and is raising $2.5 billion to support the deal at a $28.8 billion post-money valuation, Shield said on 5 November 2026. Madrona, an early Echodyne investor, published a matching note the same day confirming the $5.3 billion valuation and the early-2027 close target.

Of the $5.3 billion, $4.8 billion is to be paid and issued at closing and up to $500 million is contingent on Echodyne meeting agreed performance targets. The $2.5 billion financing mix is $1 billion Series H equity at $28.8 billion post-money, $1 billion of structured equity from funds managed by Blackstone, and $500 million of debt financing led by JPMorgan Chase Bank, N.A. as sole arranger. Closing is expected in early 2027, subject to regulatory approvals and customary conditions. Both companies said they expect triple-digit revenue growth this fiscal year — company expectations, not audited results.

In brief

  • Definitive agreement: Shield acquires Echodyne; $5.3bn value ($4.8bn at close + up to $500m contingent).
  • Raise: $2.5bn ($1bn Series H at $28.8bn post-money, $1bn Blackstone structured equity, $500m JPMorgan-led debt).
  • Close expected early 2027; still needs regulatory approvals.

What Echodyne adds to Mission Systems

Shield cast the purchase as expanding its Mission Systems business into radar and counter-drone sectors. Echodyne designs compact solid-state radars using metamaterials electronically scanned array (MESA) technology; Shield said the radars are built into hundreds of counter-drone and security systems used by defence, government and commercial customers in more than 40 countries. Civilian uses named in the release include stadium and airport protection from unauthorised drones and helping emergency services fly drones safely in shared airspace.

In September, Echodyne received a contract with a $250 million ceiling from Joint Interagency Task Force 401 to supply counter-drone radar to US and allied forces, both companies’ materials say. Echodyne’s Kirkland plant — an 86,350-square-foot facility after a $40 million investment — is described as able to produce about 30,000 radars a year. After closing, Echodyne is to keep selling MESA radars as standalone products; CEO Eben Frankenberg will report to Shield CEO Gary Steele and remain responsible for products, manufacturing and customer engagement.

Series H is co-led by Disruptive and Innovation X Capital, with participation from Advent, JPMorganChase’s Security and Resiliency Initiative Strategic Investment Group, Snowpoint Ventures, Apandion, Center15 Capital and others. Series H proceeds are principally to fund the acquisition, Shield said. Madrona’s note adds that Echodyne shareholders will join Shield’s investor base and that Echodyne will keep manufacturing in Western Washington after close.

Counter-drone sensors are becoming acquisition targets

The industrial logic is sensor scarcity, not a new doctrine speech. TSN’s recent counter-drone coverage has been about frameworks and protests as much as airframes: Germany’s Bundeswehr Tytan programme, OpenWorks’ DHS counter-drone work, BAE’s APKWS counter-drone framework, and Saildrone’s MUSV bid-protest ruling. Echodyne’s pitch to Shield is the radar layer those programmes plug into — detect and track first — at a scale Madrona says has reached hundreds of employees and 30,000-radar annual capacity in Washington state.

For UK and European integrators, the near-term question is continuity of standalone MESA supply and export process after a US defence-tech parent takes over, not a change in UK statute. The commercial caveats are the usual ones for a signed-but-unclosed deal: contingent earn-out maths, regulatory clearance, and whether Series H plus Blackstone plus JPMorgan debt is enough if the contingent tranche is earned.

Signed paper is not a closed radar company

Until early 2027’s expected close, Echodyne remains a separate seller and Shield remains a buyer with financing commitments described in a press release. Treat the $28.8 billion post-money figure as the Series H mark Shield published, not as a mark-to-market on every prior round. The contingent $500 million tranche is performance-linked; until those targets are public, investors and customers should treat headline $5.3 billion as a ceiling that still has an earn-out gate.

For UK and European buyers of MESA radars as standalone kit, the practical questions are export-control continuity, lead times out of Kirkland, and whether Shield’s Mission Systems packaging changes price lists after close. None of that is answered in today’s releases. Watch next for regulatory filings, any customer notices on supply continuity, and whether the contingent criteria are disclosed at closing. The confirmed Shield Echodyne fact today is the definitive agreement and the financing package around it — with the close still ahead.

Sources

Related stories

Follow @tsnmediahub on X for breaking AI news as it happens.

Follow on X

Share this story

Latest stories

  1. NYU Links ESCO2 Loss to PARP Inhibitor Sensitivity
    AI Science & Health

More in this category

Latest stories

  1. NYU Links ESCO2 Loss to PARP Inhibitor Sensitivity
    AI Science & Health

Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.